Lantern Pharma (LTRN) Financial Statements

Price: $3.9
Market Cap: $42.06M
Avg Volume: 92.51K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.632
52W Range: $2.79-11.99
Website: Lantern Pharma

Overview of Financial Statements

Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:

  • Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
  • Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
  • Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.

This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Lantern Pharma.


Income Statement

Breakdown December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019 December 31, 2018
Revenue $- $- $- $- $- $-
Cost of Revenue $174.84K $154.68K $97.42K $3.39K $1.63K $-2.54K
Gross Profit $-174.84K $-154.68K $-97.42K $-3.39K $-1.63K $2.54K
Gross Profit Ratio 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Research and Development Expenses $11.89M $8.60M $7.57M $2.24M $953.18K $572.10K
General and Administrative Expenses $5.98M $5.83M $5.02M $3.66M $1.48M $1.15M
Selling and Marketing Expenses $- $- $- $- $- $-
Selling General and Administrative Expenses $5.98M $5.83M $5.02M $3.66M $1.48M $1.15M
Other Expenses $- $-31.55K $160.55K $- $- $-
Operating Expenses $17.88M $14.43M $12.59M $5.91M $2.43M $1.73M
Cost and Expenses $17.88M $14.43M $12.59M $5.91M $2.43M $1.73M
Interest Income $765.39K $204.35K $67.93K $- $- $-
Interest Expense $- $204.35K $- $- $- $-
Depreciation and Amortization $174.84K $154.68K $97.42K $3.39K $1.63K $-2.54K
EBITDA $-15.79M $-14.42M $-12.27M $-5.90M $-2.43M $-1.73M
EBITDA Ratio 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Income $-17.88M $-14.43M $-12.59M $-5.91M $-2.43M $-1.73M
Operating Income Ratio 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Total Other Income Expenses Net $1.92M $172.81K $228.48K $- $- $-
Income Before Tax $-15.96M $-14.26M $-12.36M $-5.91M $-2.43M $-1.73M
Income Before Tax Ratio 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Income Tax Expense $- $-172.81K $-67.93K $-202.91K $-5 $2.54K
Net Income $-15.96M $-14.09M $-12.30M $-5.91M $-2.43M $-1.73M
Net Income Ratio 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS $-1.47 $-1.30 $-1.13 $-0.95 $-0.39 $-0.28
EPS Diluted $-1.47 $-1.30 $-1.13 $-0.95 $-0.39 $-0.28
Weighted Average Shares Outstanding 10.84M 10.85M 10.90M 6.22M 6.27M 6.22M
Weighted Average Shares Outstanding Diluted 10.84M 10.85M 10.90M 6.22M 6.27M 6.22M
SEC Filing Source Source Source Source Source Source

Balance Sheet

Breakdown December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019 December 31, 2018
Cash and Cash Equivalents $21.94M $37.20M $51.52M $19.23M $1.23M $445.16K
Short Term Investments $19.36M $17.99M $19.20M $- $- $-
Cash and Short Term Investments $41.30M $55.20M $70.73M $19.23M $1.23M $445.16K
Net Receivables $- $- $- $- $- $-
Inventory $- $-592.00K $-181.00K $- $- $-
Other Current Assets $2.47M $3.53M $1.03M $806.00K $788 $-
Total Current Assets $43.34M $58.72M $72.72M $20.24M $1.23M $445.16K
Property Plant Equipment Net $280.42K $95.69K $216.19K $21.51K $8.76K $4.67K
Goodwill $- $- $- $- $- $-
Intangible Assets $- $- $- $- $- $-
Goodwill and Intangible Assets $- $- $- $- $- $-
Long Term Investments $- $- $1.00M $- $- $-
Tax Assets $- $- $- $- $- $-
Other Non-Current Assets $25.87K $17.89K $17.89K $101.20K $191.00K $-
Total Non-Current Assets $306.29K $113.58K $1.23M $122.71K $199.76K $4.67K
Other Assets $- $- $- $- $- $-
Total Assets $43.65M $58.84M $73.95M $20.36M $1.43M $449.83K
Account Payables $- $932.41K $681.11K $432.34K $478.29K $97.63K
Short Term Debt $172.97K $52.89K $152.06K $- $- $-
Tax Payables $- $- $- $- $- $-
Deferred Revenue $- $-2.75M $-2.17M $- $- $-
Other Current Liabilities $2.51M $1.81M $1.49M $120.00K $11.00K $554.00K
Total Current Liabilities $2.68M $2.80M $2.33M $552.34K $489.29K $651.63K
Long Term Debt $61.50K $- $52.89K $108.50K $- $-
Deferred Revenue Non-Current $- $- $- $- $- $-
Deferred Tax Liabilities Non-Current $- $- $- $- $- $-
Other Non-Current Liabilities $- $- $- $- $- $-
Total Non-Current Liabilities $61.50K $52.89K $52.89K $108.50K $- $-
Other Liabilities $- $-52.89K $- $- $- $-
Total Liabilities $2.74M $2.80M $2.38M $660.84K $489.29K $651.63K
Preferred Stock $- $- $- $- $14.02K $7.43K
Common Stock $1.07K $1.09K $1.11K $622 $11.37K $11.37K
Retained Earnings $-55.24M $-39.28M $-25.02M $-12.66M $-6.75M $-4.32M
Accumulated Other Comprehensive Income Loss $-107.46K $-371.39K $-92.69K $-0 $- $-
Other Total Stockholders Equity $96.26M $95.69M $96.69M $32.36M $7.69M $4.10M
Total Stockholders Equity $40.91M $56.04M $71.57M $19.70M $943.28K $-201.80K
Total Equity $40.91M $56.04M $71.57M $19.70M $943.28K $-201.80K
Total Liabilities and Stockholders Equity $43.65M $58.84M $73.95M $20.36M $1.43M $449.83K
Minority Interest $- $- $- $- $- $-
Total Liabilities and Total Equity $43.65M $58.84M $73.95M $20.36M $1.43M $449.83K
Total Investments $19.36M $17.99M $19.20M $- $- $-
Total Debt $234.47K $52.89K $204.95K $108.50K $- $-
Net Debt $-21.70M $-37.15M $-51.32M $-19.12M $-1.23M $-445.16K

Cash Flow Statement

Breakdown December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019 December 31, 2018
Net Income $-15.96M $-14.26M $-12.36M $-5.91M $-2.43M $-1.73M
Depreciation and Amortization $14.62K $10.08K $6.76K $3.39K $1.63K $-2.54K
Deferred Income Tax $- $- $112.56K $-1.08M $251.65K $-
Stock Based Compensation $1.07M $1.19M $961.54K $1.19M $117.76K $185.60K
Change in Working Capital $538.02K $-611.86K $599.96K $-939.06K $180.88K $271.84K
Accounts Receivables $- $-158.40K $-71.66K $- $- $186.60K
Inventory $- $- $- $- $- $-
Accounts Payables $- $580.36K $1.62M $117.17K $372.66K $70.24K
Other Working Capital $538.02K $-1.03M $-950.47K $-1.06M $-191.79K $271.84K
Other Non Cash Items $-5.17K $906.49K $90.66K $1.08M $-251.65K $-76.32K
Net Cash Provided by Operating Activities $-14.35M $-12.77M $-10.59M $-5.65M $-2.13M $-1.27M
Investments in Property Plant and Equipment $-18.73K $-27.84K $-15.50K $-16.14K $-5.72K $-
Acquisitions Net $- $-179.27M $19.53B $- $- $5.34K
Purchases of Investments $-8.20M $-3.91M $-19.58M $- $- $-
Sales Maturities of Investments $7.28M $4.12M $64.09K $- $- $-
Other Investing Activities $-1 $179.27M $-19.53B $-5.72M $- $5.34K
Net Cash Used for Investing Activities $-930.21K $179.27K $-19.53M $-16.14K $-5.72K $5.34K
Debt Repayment $- $- $- $108.50K $- $-
Common Stock Issued $- $- $69.00M $26.25M $2.92M $-
Common Stock Repurchased $-500.00K $-2.48M $-939.67K $- $- $-
Dividends Paid $- $- $- $- $- $-
Other Financing Activities $- $-2.48M $-5.58M $26.25M $2.92M $535.00K
Net Cash Used Provided by Financing Activities $-500.00K $-2.18K $63.42M $23.66M $2.92M $535.00K
Effect of Forex Changes on Cash $-28.46K $-10.61K $1.07K $- $- $-
Net Change in Cash $-15.81M $-14.78M $33.30M $18.00M $786.87K $-731.18K
Cash at End of Period $21.94M $37.74M $52.52M $19.23M $1.23M $445.16K
Cash at Beginning of Period $37.74M $52.52M $19.23M $1.23M $445.16K $1.18M
Operating Cash Flow $-14.35M $-12.77M $-10.59M $-5.65M $-2.13M $-1.27M
Capital Expenditure $-18.73K $-27.84K $-15.50K $-16.14K $-5.72K $-
Free Cash Flow $-14.37M $-12.80M $-10.61M $-5.67M $-2.13M $-1.27M